The recurrent translocation t(14;20)(q32;q12) in multiple myeloma results in aberrant expression of MAFB: A molecular and genetic analysis of the chromosomal breakpoint

Keyphrases

• Aberrant Expression 100%
• Chromosome Breakage 100%
• Molecular Analysis 100%
• Genetic Analysis 100%
• Multiple Myeloma 100%
• Recurrent Translocation 100%
• Myeloma Cells 100%
• Transcription Factor 50%
• Gene Expression 50%
• Oncogene 50%
• Patient Materials 50%
• Immunofluorescence 50%
• Deregulation 50%
• Hybrid Genes 50%
• In Situ Hybridization 50%
• MRNA Expression 50%
• Derivative Chromosome 50%
• Chromosomal Translocation 50%
• Oncogenic Transformation 50%
• Bone Marrow Samples 50%
• Adverse Prognosis 50%
• Lymphoid Malignancies 50%
• Diagnostic Bones 50%
• Immunoglobulin Heavy Chain Locus 50%
• Five Cells 50%
• Breakpoint Regions 50%
• Rare Translocations 50%
• Gene-rich Regions 50%
• Ectopic Gene Expression 50%
• Double-color 50%
• Immunoglobulin Heavy Chain Gene 50%

Biochemistry, Genetics and Molecular Biology

• Genetics 100%
• Transcription Factors 100%
• Ectopic Expression 100%
• Proto Oncogene 100%
• Immunofluorescence 100%
• Intravenous Immunoglobulin 100%
• Derivative Chromosome 100%
• Chromosomal Translocation 100%
• Heavy Chain 100%
• Hybrid Gene 100%
• Immunoglobulin Heavy Chain Gene 100%
• Chromosome 20 100%
• Messenger RNA 100%
• In Situ Hybridization 100%

Immunology and Microbiology

• Cell Line 100%
• Multiple Myeloma 100%
• Transcription Factors 33%
• Ectopic Expression 33%
• Proto Oncogene 33%
• Immunofluorescence 33%
• Chromosome Translocation 33%
• Myeloma Cell Line 33%
• Myeloma Cell 33%
• Immunoglobulin Heavy Chain 33%
• Immunoglobulin Heavy Chain Gene 33%
• Chromosome 20 33%
• Hybrid Gene 33%
• In Situ Hybridization 33%